Author

Mario A. Inchiosa

New York Medical CollegeORCID 0000-0002-5933-5222Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:benchmarking· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1

Activity by Year

2023-2025 · peak 1/yr

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 1, 2025

Inhibition of Mantle Cell Lymphomas by the beta 2-Adrenergic Agonist, Levalbuterol, in Hollow Fiber Assay in Mice

Mario A. Inchiosa

This study tests levalbuterol's anti-lymphoma effects in mice, finding significant inhibition of Mantle Cell lymphoma proliferation at higher concentrations.

DOI 10.1101/2025.09.01.673249

mousebulk RNA-seq

𝕏 PostBluesky

BioinformaticsJournal of Pharmacy and Pharmacology ResearchPeer-reviewedJan 1, 2023

Further investigation of the potential anti-neoplastic, anti-inflammatory, and immunomodulatory actions of phenoxybenzamine using the Broad Institute CLUE platform.

Mario A. Inchiosa

This study investigates phenoxybenzamine's potential anti-neoplastic, anti-inflammatory, and immunomodulatory effects using the Broad Institute CLUE platform, finding gene expression similarities to known anti-proliferative agents.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky